ABCC7 p.Gly126Ser

ClinVar: c.376G>A , p.Gly126Ser ? , not provided
CF databases: c.377G>A , p.Gly126Asp (CFTR1) D ,
Predicted by SNAP2: A: N (61%), C: D (75%), D: D (71%), E: D (91%), F: D (91%), H: D (91%), I: D (85%), K: D (91%), L: D (71%), M: D (85%), N: D (75%), P: D (75%), Q: D (85%), R: D (91%), S: N (53%), T: D (59%), V: D (66%), W: D (91%), Y: D (91%),
Predicted by PROVEAN: A: N, C: D, D: D, E: D, F: N, H: D, I: N, K: D, L: N, M: N, N: D, P: D, Q: D, R: D, S: N, T: N, V: N, W: D, Y: N,

[switch to compact view]
Comments [show]
Publications
[hide] Sharma N, Acharya N, Singh SK, Singh M, Sharma U, Prasad R
Heterogenous spectrum of CFTR gene mutations in Indian patients with congenital absence of vas deferens.
Hum Reprod. 2009 May;24(5):1229-36. Epub 2009 Jan 30., [PMID:19181743]

Abstract [show]
Comments [show]
Sentences [show]

[hide] Prasad R, Sharma H, Kaur G
Molecular basis of cystic fibrosis disease: an Indian perspective.
Indian J Clin Biochem. 2010 Oct;25(4):335-41. Epub 2010 Nov 19., [PMID:21966101]

Abstract [show]
Comments [show]
Sentences [show]

[hide] Sharma H, Jollivet Souchet M, Callebaut I, Prasad R, Becq F
Function, pharmacological correction and maturation of new Indian CFTR gene mutations.
J Cyst Fibros. 2015 Jan;14(1):34-41. doi: 10.1016/j.jcf.2014.06.008. Epub 2014 Jul 16., [PMID:25042876]

Abstract [show]
Comments [show]
Sentences [show]